文献速递乳腺乳腺X线

数字乳腺X线筛查中双读片的有效性与成本效益:系统评价与Meta分析

Effectiveness and cost-effectiveness of double reading in digital mammography screening: A systematic review and meta-analysis.
PubMed 文献 · Eur J Radiol · 2017-09-21

该系统评价与Meta分析检索至2017年4月的文献,纳入4项高质量研究,比较数字乳腺X线筛查中双读片与单读片的效果与成本效益。双读片汇总癌症检出率为每1000次筛查6.01例,单读片为5.65例(P=0.76);双读片假阳性率为每1000次筛查47.03例,单读片为40.60例(P=0.12)。一项研究报告双读片每检出1例癌症的ICER为16684欧元。

要点

  • 双读片与单读片数字乳腺X线筛查的癌症检出率无显著差异(P=0.76)。
  • 双读片假阳性率数值上高于单读片,但差异未达统计学显著(P=0.12)。
  • 双读片似乎增加运营成本,证据获益有限。

核心结论

  • 双读片较单读片用于数字乳腺X线判读的获益证据 scarce;双读片似乎增加运营成本,假阳性率未显著升高,癌症检出率相似。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、Embase和Cochrane Library数据库至2017年4月,最终纳入4项高质量研究;采用QUADAS-2工具和CHEERS清单评估方法学质量;PROSPERO注册号CRD42014013804。

诊断标准与关键数值

  • 双读片汇总癌症检出率为每1000次筛查6.01例(95%CI 4.47‰-7.77‰),单读片为每1000次筛查5.65例(95%CI 3.95‰-7.65‰),P=0.76;双读片汇总假阳性率为每1000次筛查47.03例(95%CI 39.13‰-55.62‰),单读片为每1000次筛查40.60例(95%CI 38.58‰-42.67‰),P=0.12;一项研究报告双读片每检出1例癌症的ICER为16684欧元(24717美元PPP,2015年值);单读片+计算机辅助检测(CAD)在日本具有成本效益。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 双读片较单读片用于数字乳腺X线判读的获益证据 scarce。
  • 双读片似乎增加运营成本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Double reading is the strategy of choice for mammogram interpretation in screening programmes. It remains, however, unknown whether double reading is still the strategy of choice in the context of digital mammography. Our aim was to determine the effectiveness and cost-effectiveness of double reading versus single reading of digital mammograms in screening programmes.

METHODS: We performed a systematic review by searching the PubMed, Embase, and Cochrane Library databases up to April 2017. We used the QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) tool and CHEERS (Consolidated Health Economic Evaluation Reporting Standards) checklist to assess the methodological quality of the diagnostic studies and economic evaluations, respectively. A proportion's meta-analysis approach, 95% Confidence Intervals (95% CI) and test of heterogeneity (P values) were used for pooled results. Costs are expressed US$ PPP (United States Dollar purchasing power parities). The PROSPERO ID of this Systematic Review's protocol is CRD42014013804.

RESULTS: Of 1473 potentially relevant hits, four high-quality studies were included. The pooled cancer detection rate of double reading was 6.01 per 1000 screens (CI: 4.47‰-7.77‰), and it was 5.65 per 1000 screens (CI: 3.95‰-7.65‰) for single reading (P=0.76). The pooled proportion of false-positives of double reading was 47.03 per 1000 screens (CI: 39.13‰-55.62‰) and it was 40.60 per 1000 screens (CI: 38.58‰-42.67‰) for single reading (P=0.12). One study reported, for double reading, an ICER (Incremental Cost-Effectiveness Ratio) of 16,684 Euros (24,717 US$ PPP; 2015 value) per detected cancer. Single reading+CAD (computer-aided-detection) was cost-effective in Japan.

CONCLUSION: The evidence of benefit for double reading compared to single reading for digital mammography interpretation is scarce. Double reading seems to increase operational costs, have a not significantly higher false-positive rate, and a similar cancer detection rate.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Posso M, Puig T, Carles M, et al. Effectiveness and cost-effectiveness of double reading in digital mammography screening: A systematic review and meta-analysis. Eur J Radiol. 2017. PMID: 29103474. doi:10.1016/j.ejrad.2017.09.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。